Cardiology

Can using DE-MRI image scans determine the prevalence of unrecognized MIs in asymptomatic patients with diabetes?

Combination dual therapy reduces mortality by 50%.

FDA has approved a new treatment for diabetic kidney disease, which affects one in three patients with type 2 diabetes.

Is the CAC score a reliable tool in assessing cardio risk in patients with type 1 diabetes?

Study examines SGLT-2 inhibitors versus DPP-4 in reducing cardiovascular events.

Patients who have diabetes should be screened for psychological risk factors.

Combined analysis of eGFR and albuminuria over 2 years has been shown to predict T2DM patients’ risk for major macrovascular outcomes.

While cardiovascular risk factors are used to predict risk for clinical outcomes and base therapies, it may be a fluctuation in such risk factor measurements that has the most impact.

Heart failure is a common macrovascular complication that may occur in patients with diabetes, but what gender is more prone to have continuous hospitalization for heart failure problems?

Counseling patients about lifestyle modification is an important aspect of therapy.